GlassScriptPhysician profile
Donna Hagberg
NPI 1578691465
$2,180.13
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $85.71 · 2021: $254 · 2022: $568 · 2023: $553 · 2024: $104 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.45 |
| Education | $206.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $319.70 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Abbvie INC. | $314.18 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $301.07 | 2021-2023 | |
| Astellas Pharma US INC | $257.83 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $193.23 | 2019-2022 | |
| Evofem Biosciences, INC. | $116.70 | 2021-2022 | |
| Pfizer INC. | $112.61 | 2021-2024 | |
| Exact Sciences Corporation | $107.70 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $70.04 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $65.06 | 2023 | Gemtesa |
| Allergan, INC. | $58.36 | 2019-2020 | |
| Scynexis, INC. | $54.01 | 2022 | |
| Avion Pharmaceuticals | $46.64 | 2022 | |
| Coopersurgical, INC. | $43.39 | 2019-2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $38.24 | 2019-2023 | Thinprep 2000 Processor |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $23.98 | 2022 | |
| Glaxosmithkline, LLC. | $19.90 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.44 | 2019 | |
| Currax Pharmaceuticals LLC | $18.05 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Hagberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.